Construction and characterization of a Lactococcus lactis strain deficient in intracellular CIpP and extracellular HtrA proteases

Archive ouverte

Cortes-Perez, Naima | Poquet, Isabelle | Oliveira, M | Gratadoux, Jean-Jacques, J.-J. | Madsen, S M | Miyoshi, Anderson | Corthier, Gerard, G. | Azevedo, Vasco | Langella, Philippe, P. | Bermudez Humaran, Luis, L.

Edité par CCSD ; Microbiology Society -

International audience. A Lactococcus lactis strain deficient in both its major proteases, intracellular (ClpP) and extracellular (HtrA), was constructed and characterized. This strain, hereafter called clpP-htrA, could be obtained only by conjugation between a clpP donor strain and an htrA recipient strain in the NZ9000 context, allowing heterologous gene expression under the control of the NICE (nisin-controlled expression) system. The clpP-htrA double mutant showed both higher stress tolerance (e.g. high temperature and ethanol resistance) and higher viability than single clpP or htrA mutant strains. In addition, the secretion rate of two heterologous proteins (staphylococcal nuclease Nuc and Nuc-E7) was also higher in clpP-htrA than in the wild-type strain. This strain should be a useful host for high-level production and quality of stable heterologous proteins.

Consulter en ligne

Suggestions

Du même auteur

Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli

Archive ouverte | Cortes-Perez, Naima | CCSD

International audience. The human papillomavirus type-16 (HPV-16) E7 protein is considered a major viral oncoprotein involved in cervical cancer (CxCa) and a potential candidate for the development of a vaccine agai...

Controlled production of stable heterologous proteins in Lactococcus lactis

Archive ouverte | Miyoshi, Anderson | CCSD

International audience. The use of Lactococcus lactis (the most extensively characterized lactic acid bacterium) as a delivery organism for heterologous proteins is, in some cases, limited by low production levels a...

A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

Archive ouverte | Bermudez Humaran, Luis, L. | CCSD

International audience. Current strategies to prevent or treat human papillomavirus type 16 (HPV-16) infection are promising, but remain costly. More economical but efficient vaccines are thus needed. In this study,...

Chargement des enrichissements...